Education
About Us
Working with TipRanks
Follow Us
Pyxus International (PYYX)
OTHER OTC:PYYX
Top Page
Pyxus International
(OTC:PYYX)
Select Model
Select Model
Rating:46Neutral
Price Target:
$3.00
▼(-7.98% Downside)
Action:ReiteratedDate:02/24/26
The score is held down primarily by weak financial performance—steep revenue contraction, high leverage, and materially negative operating/free cash flow. Technicals are mixed with neutral momentum but longer-term trend pressure, and valuation is difficult to support due to a negative P/E and no dividend yield provided. The earnings call adds modest support through reaffirmed guidance and liquidity strength, but near-term working-capital and Q4 execution risks remain significant.
Positive Factors
Adjusted EBITDA stability
Consistent adjusted EBITDA and a reaffirmed full-year target indicate underlying operational resilience in processing and merchandising. Stable EBITDA supports coverage of fixed costs, enables reinvestment in processing capacity, and provides a predictable earnings base even with top-line volatility.
Processing margins & platform scale
Meaningful recurring margins from third‑party processing diversify revenue and leverage existing processing assets. This asset-light, fee-based activity enhances margin stability, monetizes spare capacity, and creates a durable revenue stream less dependent on leaf price cycles.
Immediate liquidity runway
Having an undrawn ABL and cash provides near-term funding flexibility to manage seasonal working capital swings and execute shipment cadence. This reduces immediate refinancing pressure and increases the odds of converting inventory to cash without distress financing.
Negative Factors
Very high leverage
Extremely elevated leverage materially limits financial flexibility and raises refinancing risk. High debt amplifies interest burden and reduces capacity to absorb cyclical revenue shortfalls, making durable investment, strategic pivots, or distress avoidance dependent on successful cash conversion.
Negative cash generation
Persistent negative operating and free cash flow means core operations do not self-fund growth or debt service. Over 2–6 months this increases reliance on drawn liquidity or capital markets, constraining capex, M&A optionality, and heightening the risk that margins must finance both operations and high interest expense.
Large inventory build & extended operating cycle
A $207M inventory build and a 184‑day cycle tie up cash and heighten seasonal funding needs. If Q4 shipments are delayed by logistics or weather, converting that stock to cash becomes risky, worsening leverage and interest coverage despite operational improvements.
Pyxus International (PYYX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)3.30K
Price to Earnings (P/E)―
Beta (1Y)-0.02
Revenue Growth10.63%
EPS Growth37.64%
CountryUS
Employees3,000
SectorConsumer Defensive
Sector Strength42
IndustryTobacco
Share Statistics
EPS (TTM)0.65
Shares Outstanding24,607,792
10 Day Avg. Volume3,410
30 Day Avg. Volume3,300
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.64
Price to Sales (P/S)0.04
P/FCF Ratio-2.82
Enterprise Value/Market Cap10.00T>
Enterprise Value/Revenue0.57
Enterprise Value/Gross Profit4.00
Enterprise Value/Ebitda7.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pyxus International Business Overview & Revenue Model
Company DescriptionPyxus International, Inc., an agricultural company, engages in the provision of value-added products and services to businesses and customers. It also involved in the purchasing, processing, packing, storing, and shipping tobacco to manufacturers of cigarettes and other consumer tobacco products. The company was formerly known as Old Holdco, Inc. Pyxus International, Inc. was founded in 1873 and is headquartered in Morrisville, North Carolina.
How the Company Makes MoneyPyxus International generates revenue primarily through the sale of processed tobacco leaves to manufacturers in the tobacco industry. The company’s revenue model is built on a combination of direct sales and long-term supply contracts with key customers, ensuring a stable income stream. Additionally, Pyxus is expanding its revenue base through its non-tobacco segments, particularly in the cannabis and hemp markets, where it develops and sells products derived from these crops. Strategic partnerships with growers and distributors also enhance their market reach and operational efficiency, contributing significantly to their earnings.
Pyxus International Earnings Call Summary
Earnings Call Date:Feb 11, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Jun 16, 2026
Earnings Call Sentiment Neutral
The call presented a mix of solid operational execution and near-term financial headwinds. Positives included stable adjusted EBITDA, improved gross margin percentage, meaningful third‑party processing margins, SG&A reductions, a strong liquidity position (undrawn ABL and $130M cash), and material sustainability achievements. Offsetting these positives were a sizable inventory build ($207M), higher working capital needs that drove a 184‑day operating cycle, a use of cash in adjusted free cash flow of $186M, elevated net interest expense, and reliance on concentrated Q4 shipments (with execution risks, particularly in Africa). Management expects Q4 shipments to convert inventory to cash and improve leverage and coverage, and they reaffirmed full-year guidance. Overall, highlights and lowlights are balanced: the company demonstrates operational strength and clear plans to address seasonal liquidity pressures, but near-term working capital and execution risks weigh on the outlook.Q3-2026 Updates
Positive Updates
Adjusted EBITDA Stability and Full-Year Guidance Reaffirmed
Adjusted EBITDA of $80.0M in Q3 was essentially consistent with prior year (record third quarter last year). Year-to-date adjusted EBITDA was $164.2M, broadly in line with last year. Management reaffirmed full-year fiscal 2026 guidance of $2.4B–$2.6B in net sales and $215M–$235M of adjusted EBITDA.
Strong Third-Party Processing Contribution
Expanded third‑party processing drove scale benefits: contributed approximately $7M of Q3 margins and $28.8M year-to-date, demonstrating the value of the company's processing expertise and flexible global platform.
Improved Gross Margin Percentage
Gross margin percentage improved modestly to 15.2% in Q3 and year-to-date gross margin percentage increased to 14.6% from 13.9% last year, supported by larger South American crops and increased third‑party processing.
SG&A Reduction and Operating Income
SG&A expense fell to $38.3M in Q3, an $8.2M improvement year-over-year, with year-to-date SG&A at $118.8M. Operating income was $51.3M for the quarter and $119M year-to-date, reflecting improved earnings quality.
Improved Equity Pickup from JV
Equity pickup from unconsolidated affiliates increased by $8.1M to $12.4M in the quarter, driven primarily by strong performance from China Brasil Tabacos (joint venture with China Tobacco International), benefitting from larger South American crops.
Strong Liquidity Position and Undrawn ABL
Liquidity remains strong with no borrowings on the $150M ABL facility and $130M of cash on hand to fund fourth-quarter shipments and seasonal maturities, supporting confidence in converting inventory to cash.
Sustainability Milestones Achieved
Released FY2025 sustainability report: achieved 2030 operational waste reduction targets ahead of schedule, recycled 30,000 metric tons of waste, and reduced Scope 1 and 2 emissions by ~7,800 metric tons (equivalent to emissions from ~1,815 gasoline cars for one year).
Visible Q4 Shipping Cadence
Management reports clear visibility into Q4 shipments (peak shipping period) and expects significant working capital release, inventory conversion to cash, seasonal line paydown, lower leverage and improved interest coverage at year-end.
Negative Updates
Quarter and Year-to-Date Net Sales Decline
Net sales for Q3 were $655.8M, a decrease of approximately $123M versus prior year. Year-to-date net sales totaled $1.7B, down about $245M versus last year, driven primarily by lower average sales prices and shipment timing.
Gross Margin Per Kilo Slightly Down
Gross margin per kilo declined to $0.80 in Q3 (slightly below prior year) and year-to-date was $0.81 versus $0.85 last year, reflecting a higher proportion of by-product volumes and product/customer mix shifts.
Working Capital and Inventory Build
Year-over-year inventory increased by $207M, principally driving a working capital use that increased the operating cycle to 184 days (a ~23-day increase). The inventory build was funded by elevated seasonal borrowings and caused the latest 12-month adjusted free cash flow to be a use of cash of $186M (including $181M use from changes in working capital).
Increased Net Interest Expense and Leverage
Net interest expense for the quarter was $36.6M, up $3.7M due to elevated seasonal funding. Reported leverage was 6.0x and interest coverage 1.4x (management expects improvement at year-end), indicating elevated near-term leverage and coverage strain.
Elevated Other Expense from Customs Settlement
Other expense was elevated in the quarter due to settlement of a long‑standing customs resolution in a specific market and FX variability, negatively impacting quarter results.
Concentration and Timing Risk in Q4 Shipments
A large portion of the expected Q4 revenue relies on shipments from Africa and South America; African shipments can be affected by port reliability and weather, introducing execution risk to Q4 conversion of inventory to cash.
Lower Average Sales Prices
Lower average selling prices contributed materially to the year-over-year revenue decline, indicating market price pressure despite stable adjusted EBITDA and margin percentage improvements.
Company Guidance
Pyxus reaffirmed fiscal 2026 guidance of $2.4–$2.6 billion in net sales and $215–$235 million of adjusted EBITDA, supported by Q3 adjusted EBITDA of $80 million and year-to-date adjusted EBITDA of $164.2 million (Q3 net sales $655.8 million; YTD sales $1.7 billion), gross margin per kilo of $0.80 in Q3 ($0.81 YTD) and gross margin percentages of 15.2% (Q3) and 14.6% (YTD), plus contributions from third‑party processing of ~$7 million in Q3 and $28.8 million YTD; management expects Q4 peak shipments to convert elevated inventory (Y/Y increase $207 million; uncommitted inventory 3.6% of processed inventory) into cash, materially reduce seasonal borrowings, improve the 184‑day operating cycle, lower leverage (currently ~6 turns) and raise interest coverage (currently ~1.4x), and thereby improve adjusted free cash flow (latest 12‑month adjusted free cash flow was a $186 million use, including $181 million from working‑capital changes); liquidity remains strong with no borrowings on the $150 million ABL and $130 million of cash.Pyxus International Financial Statement Overview
Summary
Financials are pressured by a sharp TTM revenue decline (-33%), very high leverage (TTM debt ~$1.29B vs equity ~$161M; ~8.0x debt-to-equity), and deeply negative cash generation (TTM operating cash flow -$360M; free cash flow -$384M). Positive EBIT/EBITDA margins and occasional profitability are outweighed by persistent cash burn and balance-sheet risk.Income Statement
TTM (Trailing-Twelve-Months) revenue fell sharply (-33.0%), signaling meaningful top-line pressure. Profitability shows mixed progress: operating margins are positive (about 5.2% EBIT and 9.4% EBITDA), but net results remain slightly negative (net margin about -0.3%). Historically, the company has swung between losses and small profits (annual net income positive in FY2024–FY2025, negative in FY2022–FY2023), suggesting earnings are not yet consistently durable.38
Negative
Balance Sheet
Leverage is very high: TTM (Trailing-Twelve-Months) debt is ~$1.29B versus equity of ~$161M (debt-to-equity ~8.0x), leaving limited balance-sheet flexibility. While equity is positive, the company’s returns to shareholders are weak (TTM return on equity is negative), and leverage has generally stayed elevated across the period (roughly ~5.5x to ~7.5x in most annual years), increasing refinancing and downturn risk.22
Negative
Cash Flow
Cash generation is a key weakness. TTM (Trailing-Twelve-Months) operating cash flow is deeply negative (-$360M) and free cash flow is also materially negative (-$384M), indicating the business is consuming cash rather than funding itself. Annual results are consistently negative on both measures as well, which raises dependence on external financing and heightens balance-sheet risk, particularly given the already high leverage.14
Very Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.24B | 2.48B | 2.03B | 1.91B | 1.64B | 1.33B |
| Gross Profit | 319.07M | 342.98M | 312.33M | 261.02M | 227.06M | 151.46M |
| EBITDA | 162.53M | 181.83M | 160.18M | 117.20M | 97.57M | 6.10M |
| Net Income | -4.95M | 15.17M | 2.66M | -56.75M | -92.00M | -117.65M |
Balance Sheet | ||||||
| Total Assets | 1.92B | 1.50B | 1.66B | 1.58B | 1.70B | 1.54B |
| Cash, Cash Equivalents and Short-Term Investments | 129.84M | 78.25M | 92.57M | 136.73M | 198.78M | 92.70M |
| Total Debt | 1.34B | 877.99M | 1.05B | 1.04B | 1.10B | 964.57M |
| Total Liabilities | 1.75B | 1.34B | 1.51B | 1.44B | 1.52B | 1.29B |
| Stockholders Equity | 161.25M | 160.09M | 142.28M | 137.85M | 175.28M | 247.67M |
Cash Flow | ||||||
| Free Cash Flow | -383.96M | -36.41M | -236.01M | -154.13M | -213.59M | -250.92M |
| Operating Cash Flow | -360.27M | -13.39M | -214.97M | -137.82M | -198.76M | -226.54M |
| Investing Cash Flow | 181.92M | 170.64M | 159.45M | 154.94M | 181.24M | 133.48M |
| Financing Cash Flow | 204.61M | -167.26M | 25.56M | -83.00M | 123.26M | 14.35M |
Pyxus International Technical Analysis
Negative
3.26
Price Trends
3.06
Negative
3.08
Negative
3.81
Negative
Market Momentum
-0.06
Negative
46.85
Neutral
56.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PYYX, the sentiment is Negative. The current price of 3.26 is above the 20-day moving average (MA) of 2.92, above the 50-day MA of 3.06, and below the 200-day MA of 3.81, indicating a bearish trend. The MACD of -0.06 indicates Negative momentum. The RSI at 46.85 is Neutral, neither overbought nor oversold. The STOCH value of 56.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PYYX.
Pyxus International Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $290.83B | 25.72 | ― | 3.59% | 7.72% | -12.45% | |
69 Neutral | $135.31B | 13.54 | 15.94% | 5.22% | 0.48% | ― | |
69 Neutral | $2.61B | 48.23 | 22.54% | 0.28% | 6.71% | 8.16% | |
66 Neutral | $115.43B | 16.77 | ― | 7.02% | -0.96% | -11.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | $1.34B | 15.87 | 5.81% | 6.15% | 3.01% | -7.14% | |
46 Neutral | ― | -14.06 | -3.58% | ― | 10.63% | 37.64% |
* Consumer Defensive Sector Average
PYYX
Pyxus International
2.89
-2.06
-41.62%
MO
Altria Group
69.04
15.56
29.09%
BTI
British American Tobacco
62.65
25.32
67.81%
PM
Philip Morris
186.83
33.46
21.82%
UVV
Universal
53.73
2.89
5.69%
TPB
Turning Point Brands
136.99
66.91
95.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.